Mobia Medical Q1 FY26 net loss widens 66.5% to $17.74 million; revenue more than doubled to $12.07 million
Mobia Medical, Inc. MOBI | 0.00 |
- Mobia Medical posted a net loss of USD 17.74 million for Q1, widening from USD 10.65 million a year earlier.
- Revenue more than doubled to USD 12.07 million, up 113.3% year over year.
- Gross margin edged up 0.2 percentage points to 82.3%.
- Selling, general and administrative expenses climbed to USD 25.19 million, up 85.2% on higher headcount, fees, travel, marketing.
- Cash and cash equivalents totaled USD 55.7 million as of March 31, 2026; net proceeds from the May IPO were about USD 134.5 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mobia Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-257552), on June 04, 2026, and is solely responsible for the information contained therein.
